Filter posts

BIO Strongly Supports R&D Tax Credit Legislation

The House Ways and Means Committee posted the following message on its home page showing the support …

Sanofi’s Chris Viehbacher: Trust, Respect Key in Pharma-Biotech Partnerships

How can large pharmaceutical and small biotech companies form mutually beneficial partnerships that harness the …

The Hill's Congress Blog: Innovation in medicine isn't optional - it's imperative

Earlier this week, The Hill’s Congress Blog posted an op-ed penned by Andrew von Eschenbach …

BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry

Innovative biotech companies at all stages of the development process are working toward next generation …

Fewer Small Public Biotechs Today

A lot can happen in six years. The number of active biotech companies currently trading …

Emerging Company Policy Deconstructed: Fostering Innovation Act (H.R. 2629)

In a nutshell: Representative Michael Fitzpatrick (R-PA) introduced H.R. 2629, the Fostering Innovation Act, to …

Emerging Company Policy Deconstructed: Small Cap Liquidity Reform Act (H.R. 3448)

In a nutshell: This bill, sponsored by Reps. Sean Duffy (R-WI) and John Carney (D-DE), …

Emerging Company Policy Deconstructed: Start-up Jobs and Innovation Act (S. 1658)

In a nutshell: Senators Robert Menendez (D-NJ) and Pat Toomey (R-PA) introduced the Start-up Jobs …

JOBS Act Deconstructed: Confidential Filing

More than 40 biotech companies have gone public using provisions made available to emerging growth …

JOBS Act Deconstructed: Testing-the-Waters

More than 40 biotech companies have gone public using provisions made available to emerging growth …